Ariela R Orkaby

Harvard Medical School

$2,779,996

Attributed

$2,779,996

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY2018–25

$2M$1.5M$1M$500K$0

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,779,996 · 2

VA$0 · 1

By mechanism

R01$2,586,946 · 1

R03$193,050 · 1

IK2$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Harvard Medical School

Same institution · by research overlap

Marcia Haigis$12,366,449
Rahul Gupta$186,301
Laura Anne Jacox$1,665,065
Joseph Pickrell$1,138,198
Ying Lu$2,094,034

Others in their field

Other Emerging Leaders on “Cessation Of Life”

Xinhua Li · Nano Terra, Inc.$32,520,955
Christopher Barnaby Nelson · University Of Melbourne$27,954,628
Abraham Aizer Brody · New York University School Of Medicine$21,799,826
Peter W Pisters · University Of Tx Md Anderson Can Ctr$20,810,724
Jeffrey Reich · Sparian Biosciences, Inc.$20,633,040
Beth Baseler · Leidos Biomedical Research, Inc.$18,109,529

Research focus

Cessation Of LifePharmaceutical PreparationsPreventionVeteransFollow-UpElderlyIndexingPreventFrailtyStrokeCardiovascular Disorder PreventionAgingCholesterolCardiovascular DiseasesEventClinical TrialsCareer DevelopmentGait SpeedGeriatricsAdultCareerGuidelinesCardiovascular Disorder RiskCardiology